What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations?

References

• APPLEBY, L., SHAW, J., AMOS, T. et al. (1999). Suicide within 12 months of contact with mental health services: national clinical survey. British Medical Journal, 318, 1235–1239.
   PubMed Web of Science ®Google Scholar
• A° SBERG, M., MONTGOMERY, S., PERRIS, C. et al. (1978). A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica, 271(Suppl.), 5–27.
   Google Scholar
• BANERJEE, S., CLANCY, C. & CROME, I. (Eds) (2002). Co-existing Problems of Mental Disorder and Substance Misuse (Dual Diagnosis): an information manual. London: The Royal College of Psychiatrists’ Research Unit.
   Google Scholar
• BARROWCLOUGH, C., HADDOCK, G., TARRIER, N. et al. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706–13.
   PubMed Web of Science ®Google Scholar
• BROONER, R.K., KING, V.L, KIDORF, M. et al. (1997). Psychiatric and substance misuse comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71–80.
   PubMed Web of Science ®Google Scholar
• CAREY, M.P., CAREY, K.B. & MEISLER, A.W. (1991). Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease, 179, 136–138.
   PubMed Web of Science ®Google Scholar
• DEPARTMENT OF HEALTH (1998). Modernising Mental Health Services. London: Department of Health.
   Google Scholar
• DEPARTMENT OF HEALTH (2002). Mental Health Policy Implementation Guide: dual diagnosis good practice guide. London: Department of Health.
   Google Scholar
• DEPARTMENT OF HEALTH AND HUMAN SERVICES (1999). Mental Health: A report of the Surgeon General. Rockville, MD, USA: Department of Health and Human Services, National Institute of Mental Health.
   Google Scholar
• DRAKE, R.E., MERCER-MCFADDEN, C., MUESER, K.T. et al. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589–608.
   PubMed Web of Science ®Google Scholar
• DRIESSEN, M., VELTRUP, C., WEBER, J. et al. (1998). Psychiatric comorbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction, 93, 889–894.
   PubMed Web of Science ®Google Scholar
• DUKE, P.J., PANTELIS, C., MCPHILLIPS, M.A. & BARNES, T.R.E. (2001). Comorbid substance misuse among people with schizophrenia in the community: an epidemiological study in central London. British Journal of Psychiatry, 179, 501–513.
   Web of Science ®Google Scholar
• GOSSOP, M., DARKE, S., GRIFFITHS, P. et al. (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.
   PubMed Web of Science ®Google Scholar
• HALL, W. & FARRELL, M. (1997). Comorbidity of mental disorders with substance misuse. British Journal of Psychiatry, 171, 4–5.
   PubMed Web of Science ®Google Scholar
• HAYWOOD, T.W., KRAVITZ, H.M., GROSSMAN, L.S. et al. (1995). Predicting the ‘revolving door’ phenom- enon among patients with schizophrenic, schizoaffective and affective disorders. American Journal of Psychiatry, 152, 856–61.
   PubMed Web of Science ®Google Scholar
• HUNT, G.E., BERGEN, J. & BASHIR, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research, 54, 253–264.
   PubMed Web of Science ®Google Scholar
• JOHNSON, S. (1997). Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? British Journal of Psychiatry, 171, 205–208.
   PubMed Web of Science ®Google Scholar
• KESSLER, R.C., MCGONAGLE, K.A., ZHAO, S. et al. (1994). Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Archives of General Psychiatry, 51, 8–19.
   PubMed Web of Science ®Google Scholar
• LEY, A., JEFFERY, D.P., MCLAREN, S. & SIEGFRIED, N. (1999). Treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). In: The Cochrane Library Issue 2. Oxford: Update Software.
   Google Scholar
• MCGUFFIN, P., FARMER, A.E. & HARVEY, I. (1991). A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764–770.
   PubMed Web of Science ®Google Scholar
• MENEZES, P.R., JOHNSON, S., THORNICROFT, G. et al. (1996). Drug and alcohol problems among individuals with severe mental illness in South London. British Journal of Psychiatry, 168, 612–619.
   PubMed Web of Science ®Google Scholar
• MINER, C.R., ROSENTHAL, R.N., HELLERSTEIN, D.J. & MUENZ, L.R. (1997). Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Archives of General Psychiatry, 54, 706–712.
   PubMed Web of Science ®Google Scholar
• MONTGOMERY, S.A. & A° SBERG, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
   Google Scholar
• MUESER, K.T., BELLACK, A.S. & BLANCHARD, J.J. (1997). Comorbidity of schizophrenia and substance abuse: implications for treatment. In G.A. Marlatt & G.G. VandenBos (eds), Addictive behaviors: readings on etiology, prevention, and treatment. New York: Pergamon Press.
   Google Scholar
• NATIONAL TREATMENT AGENCY FOR SUBSTANCE MISUSE (2002). Models of Care for the Treatment of Drug Misusers. London: National Treatment Agency for Substance Misuse.
   Google Scholar
• PHELAN, M., SLADE, M., THORNICROFT, G. et al. (1995). The Camberwell Assessment of Need: the validity & reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry, 167, 589–595.
   PubMed Web of Science ®Google Scholar
• REGIER, D.A., FARMER, M.E., RAE, D.S. et al. (1990). Comorbidity of mental disorder with alcohol and other drug abuse: results from an epidemiological catchment area (ECA) study. Journal of the American Medical Association, 264, 2511–2518.
   PubMed Web of Science ®Google Scholar
• ROTH, A & FONARGY, P. (1996) What works for whom? A critical review of psychotherapy research. London: Guilford Press.
   Google Scholar
• SANDFORD, T. (1995). Drug use is increasing. Nursing Times, 9, 16.
   Google Scholar
• SAUNDERS, J.B., AASLAND, O.G., BABOR, T.F. et al. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction, 88, 791–804.
   PubMed Web of Science ®Google Scholar
• SCOTT, H., JOHNSON, P., MENEZES, P. et al. (1998). Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345–350.
   PubMed Web of Science ®Google Scholar
• SPSS (1999). SPSS for Windows, Version 10.0.5. Chicago, IL: SPSS, Inc.
   Google Scholar
• SWARTZ, M.S., SWANSON, J.W., HIDAY, V.A. et al. (1998). Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. American Journal of Psychiatry, 155, 226–231.
   PubMed Web of Science ®Google Scholar
• TYRER, P. (2000). Quick Personality Assessment Schedule: PAS-Q. In P. Tyrer (ed.), Personality disorders: diagnosis, management and course, 2nd edn, (pp. 181–190). London: Edward Arnold.
   Google Scholar
• TYRER, P., OWEN, R.T. & CICCHETTI, D.V. (1984). The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 970–975.
   PubMed Web of Science ®Google Scholar
• WAGNER, E.H. & SIMON, G.E. (2001). Managing depression in primary care. British Medical Journal, 322, 746—747.
   PubMedGoogle Scholar
• WEAVER, T., RENTON, A., STIMSON, G. & TYRER, P. (1999). Severe mental illness and substance misuse comorbidity: research is needed to inform policy and service development. British Medical Journal, 318, 37–8.
   Google Scholar
• WEAVER, T., HICKMAN, M., RUTTER, D. et al. (2001). The prevalence and management of mental illness and substance misuse comorbidity in current mental health and substance misuse treatment populations. Drug and Alcohol Review, 20, 407–416.
   Web of Science ®Google Scholar
• WEAVER, T., MADDEN, P., CHARLES, V., STIMSON, G., RENTON, A., TYRER, P., BARNES, T., BENCH, C., MIDDLETON, H., WRIGHT, N., PATERSON, S., SHANAHAN, W., SEIVEWRIGHT, N. & FORD, C. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304–313.
   Google Scholar
• WILLIAMS, K. (1999). Attitudes of mental health professionals to comorbidity between mental health problems and substance misuse. Journal of Mental Health, 8, 605–613.
   Google Scholar
• WRIGHT, S., GOURNAY, K., GLORNEY, E. & THORNICROFT, G. (2000). Dual diagnosis in the suburbs: prevalence, need and in-patient service use. Social Psychiatry & Psychiatric Epidemiology, 35, 297–304. ZIEDONIS, D. & TRUDEAU, K. (1997) Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophrenia Bulletin, 23, 229–238.
   Google Scholar